Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination
Yamada, M.; Kamberos, N.; Grose, C.
Journal of Pediatrics 163(5): 1511-1513
2013
ISSN/ISBN: 1097-6833 PMID: 23932212 DOI: 10.1016/j.jpeds.2013.06.043
Accession: 037326808
A boy with Hodgkin disease contracted breakthrough varicella from his father, who had chickenpox. The boy had received a single varicella vaccination and was seropositive by enzyme-linked immunosorbent assay before being diagnosed with breakthrough varicella. Seropositivity after a single varicella vaccination does not guarantee complete protection in an immunocompromised child.
PDF emailed within 0-6 h: $19.90
Related References
Kelley, J.; Tristram, D.; Yamada, M.; Grose, C. 2015: Failure of a Single Varicella Vaccination to Protect Children with Cancer from Life-Threatening Breakthrough Varicella Pediatric Infectious Disease Journal 34(9): 1027-1029Leung, J.; Broder, K.R.; Marin, M. 2017: Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review Expert Review of Vaccines 16(4): 391-400
Bernstein, H.H.; Rothstein, E.P.; Watson, B.M.; Reisinger, K.S.; Blatter, M.M.; Wellman, C.O.; Chartrand, S.A.; Cho, I.; Ngai, A.; White, C.J. 1993: Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine Pediatrics 92(6): 833-837
Wurtz, R.; Check, I.J. 1999: Breakthrough varicella infection in a healthcare worker despite immunity after varicella vaccination Infection Control and Hospital Epidemiology 20(8): 561-562
Ihara, T.; Kato, T.; Torigoe, S.; Oitani, K.; Isaji, M.; Ito, M.; Kamiya, H.; Sakura, M. 1991: Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization Acta Paediatrica Japonica: Overseas Edition 33(1): 43-49
Black, S.; Ray, P.; Shinefield, H.; Saddier, P.; Nikas, A. 2008: Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program Journal of Infectious Diseases 197 Suppl. 2: S139-S142
Streng, A.; Grote, V.; Carr, D.; Hagemann, C.; Liese, J.G. 2013: Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011 BMC infectious diseases 13: 303
Littlewood, K.J.; Ouwens, M.J.N.M.; Sauboin, C.; Tehard, B.; Alain, S.; Denis, F.ço. 2015: Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster Clinical Therapeutics 37(4): 830-841.E7
Prince, N.J.; Taj, M.; Bate, J.M. 2021: Up to a Quarter of Children with Cancer Develop Breakthrough Clinical Varicella Despite Receiving Post-exposure Prophylaxis with Varicella Immunoglobulin: a Single Center UK Experience over 3 Years Journal of Pediatric Hematology/Oncology 43(1): 36-37
Terada, K.; Kawano, S.; Yoshihiro, K.; Morita, T. 1992: Persistently high antibody titers and deficient specific cellular immunity to varicella-zoster virus in a retarded patient after varicella infection Acta Paediatrica Japonica: Overseas Edition 34(4): 459-465
Galil, K.; Watson, B.; Peterson, C.; Mascola, L.; Pelosi, J.; Seward, J.; Zhang, J.; Maupin, T.; Goldman, G.; Perella, D.; Waites, C.; Tabony, L.; Wharton, M. 2001: Breakthrough varicella cases since vaccine licensure in the varicella active surveillance project Pediatric Research 49(4 Part 2): 150A
Davis, M.M.; Marin, M.; Cowan, A.E.; Guris, D.; Clark, S.J. 2007: Physician attitudes regarding breakthrough varicella disease and a potential second dose of varicella vaccine Pediatrics 119(2): 258-264
Pan, X.; Shu, M.; Ma, R.; Fang, T.; Dong, H.; Sun, Y.; Xu, G. 2018: Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China Vaccine 36(37): 5665-5670
Qin, W.; Xu, X-Kang.; Wang, Y.; Meng, X-Mei.; Yang, C-Wu.; Xia, F.; Su, H. 2020: Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks Human Vaccines and Immunotherapeutics 16(8): 1851-1856
Zhu, Y.F.; Li, Y.F.; Du, Y.; Zeng, M. 2017: Epidemiological characteristics of breakthrough varicella infection during varicella outbreaks in Shanghai, 2008-2014 Epidemiology and infection 145(10): 2129-2136
Park, C.S.; Kim, D.S.; Kim, K.H. 2013: Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence Clinical and Experimental Vaccine Research 2(2): 140-143
Pan, X.; Ma, R.; Fang, T.; Xu, G. 2015: Varicella breakthrough infection and vaccine effectiveness with 1-dose varicella Zhonghua Yu Fang Yi Xue Za Zhi 49(7): 611-614
Zhu, S.; Zeng, F.; Xia, L.; He, H.; Zhang, J. 2018: Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis American Journal of Infection Control 46(1): E1-E7
Lopez, A.S.; Kolasa, M.S.; Seward, J.F. 2008: Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program Journal of Infectious Diseases 197 Suppl. 2: S76-S81
Shinefield, H.R.; Black, S.B.; Staehle, B.O.; Matthews, H.; Adelman, T.; Ensor, K.; Li, S.; Chan, I.; Heyse, J.; Waters, M.; Chan, C.Y.; Vessey, S.J.Rupert.; Kaplan, K.M.; Kuter, B.J. 2002: Vaccination with measles, mumps and rubella vaccine and varicella vaccine: Safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children Pediatric Infectious Disease Journal 21(6): 555-561